Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12188/30186| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Iskra Velevska | en_US |
| dc.contributor.author | Jovana Aleksov | en_US |
| dc.contributor.author | Evgenija Mihajloska | en_US |
| dc.contributor.author | Aleksandar Dimkovski | en_US |
| dc.contributor.author | Irina Panovska-Stavridis | en_US |
| dc.contributor.author | Milena Stevanovic | en_US |
| dc.contributor.author | Aleksandra Grozdanova | en_US |
| dc.date.accessioned | 2024-05-15T08:02:25Z | - |
| dc.date.available | 2024-05-15T08:02:25Z | - |
| dc.date.issued | 2022 | - |
| dc.identifier.uri | http://hdl.handle.net/20.500.12188/30186 | - |
| dc.language.iso | en | en_US |
| dc.relation.ispartof | Macedonian pharmaceutical bulletin | en_US |
| dc.title | Use of tocilizumab for treatment of COVID-19 from off-label to extended indication | en_US |
| dc.type | Other | en_US |
| dc.identifier.doi | 10.33320/maced.pharm.bull.2022.68.03.277 | - |
| item.grantfulltext | none | - |
| item.fulltext | No Fulltext | - |
| crisitem.author.dept | Faculty of Medicine | - |
| crisitem.author.dept | Faculty of Pharmacy | - |
| crisitem.author.dept | Faculty of Medicine | - |
| Appears in Collections: | Faculty of Medicine: Other | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.